Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MaisaCorp Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1370906497.png) MAISA [@MaisaCorp](/creator/twitter/MaisaCorp) on x 3118 followers
Created: 2025-07-22 14:05:55 UTC

$ATYR aTyr Pharma Announces Last Patient Visit In Its Phase X EFZO-FITâ„¢ Study Of  Efzofitimod In Patients With Pulmonary Sarcoidosis

Topline results expected in the third quarter of 2025.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947659375851544898/c:line.svg)

**Related Topics**
[$atyr](/topic/$atyr)

[Post Link](https://x.com/MaisaCorp/status/1947659375851544898)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MaisaCorp Avatar MAISA @MaisaCorp on x 3118 followers Created: 2025-07-22 14:05:55 UTC

$ATYR aTyr Pharma Announces Last Patient Visit In Its Phase X EFZO-FITâ„¢ Study Of Efzofitimod In Patients With Pulmonary Sarcoidosis

Topline results expected in the third quarter of 2025.

XXX engagements

Engagements Line Chart

Related Topics $atyr

Post Link

post/tweet::1947659375851544898
/post/tweet::1947659375851544898